-
Advertisement
Short selling
BusinessMarkets

Feihe’s shares jump in Hong Kong after Chinese milk producer rejects attack by short seller, forecasts even higher sales

  • China Feihe describes allegations of inflated sales as “inaccurate and misleading” in stock exchange filing
  • Blue Orca alleges milk producer inflated sales to boost profitability; Feihe issues alert on higher sales in response

Reading Time:2 minutes
Why you can trust SCMP
A picture of Zhang Ziyi in an advertisement for China Feihe. Photo:zz-infos.com
Yujing Liu

Shares of China Feihe jumped by the most in three months in Hong Kong after the producer of mainland’s bestselling infant milk formula batted away another report by activist short-seller accusing it of cooking the books.

The stock rose 7.2 per cent to HK$16.96 at the close of trading. It earlier slumped by as much as 8.5 per cent to HK$14.48, the largest intraday loss since mid-May, after US-based Blue Orca accused the company of faking its profit and loss accounts.

Blue Orca alleged that Feihe inflated its revenues and understated its advertising and labour costs to exaggerate its profitability. It has a target price of HK$5.67 for the stock, or 64 per cent below its closing price on Tuesday, according to the report.

Advertisement

Feihe, which counts Crouching Tiger Hidden Dragon actress Zhang Ziyi as its brand ambassador, “vigorously denies the relevant allegations contained in the report and considers them to be inaccurate and misleading,” it said in a filing to the stock exchange published at Wednesday noon.

A picture of Zhang Ziyi in an advertisement for China Feihe. Photo:zz-infos.com
A picture of Zhang Ziyi in an advertisement for China Feihe. Photo:zz-infos.com
Advertisement

The Beijing-based company in turn issued a positive alert, saying its revenue probably increased by more than 40 per cent in the first half of this year from a year ago, according to the exchange filing. The increase was a result of a substantial rise in sales of high-end infant milk formula, it said.

This is not Feihe’s first brush with controversy since its initial public offering last November, when it raised HK$6.7 billion (US$864 million) in a stock sale that was oversubscribed by up to 10 times.
Advertisement
Select Voice
Select Speed
1.00x